Online ISSN: 3007-0244,
Print ISSN:  2410-4280
 



RADIOIODINE-RESISTANT DIFFERENTIATED THYROID CANCER: CLINICOPATHOLOGICAL CHARACTERISTICS, MOLECULAR GENETIC ALTERATIONS. REVIEW.

... however, 5% to 15% of DTC and 50% of metastatic DTC are not amenable to radioactive iodine I131 therapy. Some patients suffer from recurrent disease after complex treatment. Recurrent disease is often resistant to radioiodine and shows a poor response to radioactive iodine therapy. The aim. To analyze the publications devoted to the problems of radioiodine-resistant thyroid cancer and their clinicopathological and molecular-genetic characteristics. Search strategy. The literature search was performed ...

Изменен: 28.04.2024
Путь: Главная / Home / Publications
RADIOIODINE-RESISTANT DIFFERENTIATED THYROID CANCER: CLINICOPATHOLOGICAL CHARACTERISTICS, MOLECULAR GENETIC ALTERATIONS. REVIEW.

2 2024

Изменен: 28.04.2024
Путь: Главная / Публикации
Результаты поиска 1 2 из 2
Начало | Пред. | 1 | След. | Конец

Сортировать по релевантности | Отсортировано по дате